Philips' First Quarter Results 2012 - Healthcare Sector

PhilipsPhilips Healthcare sales grew nine percent to EUR 2.21 billion, with very strong growth of 27% in growth geographies. Comparable equipment order intake grew seven percent year-on-year, with the strongest contribution from Patient Care & Clinical Informatics (PCCI). Earnings (EBITA) came in at EUR 225 million, or 10.2 percent of sales.

"I am encouraged by our results in the first quarter of 2012, which is a further step in the right direction for Philips on our path to value to achieve the mid-term 2013 financial targets...Healthcare sales and order intake showed robust growth," said Frans van Houten, CEO of Royal Philips Electronics. "We remain cautious about the remainder of 2012 given the uncertainties in Europe, particularly in the healthcare and construction markets, and the slowing growth rate in the global economy."

Philips Healthcare also noted several business highlights:

  • As a leader in home health care solutions, Philips has strengthened its respiratory care portfolio with the introduction of SimplyGo, an innovative portable oxygen concentrator that helps homecare providers manage the therapy and lifestyle needs of nearly all oxygen users.
  • In partnership with Smit Mobile Equipment, Philips has introduced a mobile MicroDose unit in the Middle East. The MicroDose system, a unique low-dose digital mammography solution, has been installed in a mobile breast cancer screening vehicle specifically adapted to the local requirements.
  • Demonstrating its imaging systems leadership position and innovation progress in China, Philips achieved a major milestone having received more than 100 purchase orders for its Brilliance 256-slice iCT scanner since the introduction of this state-of-the-art system in this region.
  • At its annual meeting, the American College of Cardiology (ACC), a 39,000-member non-profit medical society, dedicated to enhancing the lives of cardiovascular patients, has partnered with Philips to showcase the newest minimally invasive techniques to treat cardiovascular disease, including multi-modality imaging, dose reduction solutions and advanced robotic-assisted systems.
  • As part of its commitment to offer customized services to support the operational performance goals of healthcare organizations, Philips has signed a five-year maintenance services contract with Tanzania’s Ministry of Health, which encompasses 120 hospitals in the country.

Philips CEO Frans van Houten comments on Q1

Related news articles:

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified health and well-being company, focused on improving people's lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity." Headquartered in the Netherlands, Philips employs approximately 122,000 employees with sales and services in more than 100 countries worldwide. With sales of EUR 22.6 billion in 2011, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in male shaving and grooming, portable entertainment and oral healthcare.

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...